Head-to-head · WeighScore
Found vs Klinic
The verdict
Found takes it — 83.5/100 to 60.8/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Found | Klinic |
|---|---|---|
| WeighScore | 83.5/100 | 60.8/100 |
| Grade | B | C |
| Scorecard rank | #10 | #349 |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | Varies (branded medication; visits extra) |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | Varies (branded medication; visits extra) |
| Coverage | All 50 states | Nationwide; confirm provider availability |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #10 · B
Strengths
- Widest medication list in this ranking — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
- Flat pricing as the dose increases, so a titration does not raise the monthly cost
- Bills insurance for the clinical visits — the site states most members pay under $30 per visit
- Runs a dedicated GLP-1 microdose program for people who want a lower starting dose
Where it loses points
- The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
- Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
- The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
- Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are
Graded #349 · C
Strengths
- Offers provider matching, insurance verification and prior-authorization support
- Wegovy, Zepbound and oral Wegovy treatment pages are published
- Zepbound program describes assistance with insurance appeals
- Publishes self-pay visit fees: from $99 initially and $75 for follow-ups
Where it loses points
- Medication is extra; there is no single published total covering visits and every prescription
- Insurance acceptance and benefit verification do not guarantee payment
- Terms describe monthly membership renewal and cancellation notice 14 business days before billing; confirm applicability to your plan
- Care is delivered by independent practitioners; confirm the provider and dispensing pharmacy before starting
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.